Abstract
In recent years, due to the influence of living habits and smoking, the number of lung cancer patients worldwide has increased year by year, and it has gradually developed into one of the common diseases endangering human life. CEUS can observe the lesion and realize the rapid identification of the location of the active area of the lesion. CEUS is the abbreviation of contrast‐enhanced ultrasound technology. Contrast‐enhanced ultrasound technology is to inject ultrasound contrast agent through a peripheral vein to perform ultrasound exploration to observe the enhancement of the internal nodules. Compared with color ultrasound, it can diagnose more accurately and improve the inspection effect. At present, this technology is used for the diagnosis of many types of space‐occupying lesions, but it is rarely used for the diagnosis of lung lesions. The purpose of this study is to explore the role of CEUS quantitative parameters combined with lung biopsy in the assessment of benign and malignant peripheral lung diseases. Based on the relevant theoretical basis of CEUS and lung biopsy, 158 patients with peripheral lung disease were selected as experimental subjects, and they were divided into experimental group and control group for comparative experiments. Experiments proved the effectiveness of CEUS quantitative parameters combined with lung biopsy methods. The experimental results showed that, compared with the benign group, the time‐intensity curve, the rise time, and the peak time of the malignant lesions were significantly prolonged. In addition, CEUS combined with the quantitative parameters of lung biopsy can effectively distinguish the activity of lung lesions and the site of necrosis and promote the effective increase of the positive rate of lung biopsy.
Highlights
The purpose of this study is to explore the role of contrast-enhanced ultrasound quantitative parameters combined with lung biopsy in the evaluation of the effect of pulmonary peripheral lesions benign and malignancy and function; the author based on the related theory of ultrasonic imaging and lung biopsy selected the 158 patients with lung lesions as experimental object; this paper will be divided into the experimental group and control group, comparison between the two groups of experiments, and through the experiment, it proved the ultrasonic imaging quantitative parameters’ effectiveness of the united way of lung biopsy [5, 6]
Contrast-enhanced ultrasound (CEUS) was used to detect the lesions around the lung, and time-intensity curves were analyzed from the acquisition of dynamic images, and relevant quantitative parameters were obtained
Based on contrastive analysis experiments, the author explored the role of CEUS quantitative parameters combined with lung biopsy in the evaluation of benign and malignant peripheral pulmonary lesions
Summary
Lung cancer is one of the serious diseases that threaten human life and health. Lung cancer poses a serious threat to the life safety of patients. CT, X-ray, and fiberoptic bronchoscopy are common methods of clinical diagnosis, and their diagnostic value has been recognized. These diagnostic methods still have shortcomings in terms of body radiation and high diagnostic cost. Contrast-enhanced ultrasound (CEUS) is a new imaging technology. Based on contrast-enhanced ultrasound, lung biopsy can be performed. Contrast-enhanced ultrasound (CEUS) is often used in the Journal of Sensors examination of abdominal lesions, but rarely in the clinical study of pulmonary lesions. The assessment of benign and malignant peripheral pulmonary lesions has a direct impact on the treatment of pulmonary diseases, and the timely assessment of benign and malignant lesions can buy sufficient time for the treatment of patients
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.